Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)

被引:2
|
作者
Uttarilli, Anusha [1 ,2 ]
Pasumarthi, Divya [1 ]
Ranganath, Prajnya [1 ,3 ]
Dalal, Ashwin B. [1 ]
机构
[1] Ctr DNA Fingerprinting & Diagnost, Div Diagnost, 4-1-714 Tuljaguda Complex,Mozamzahi Rd, Hyderabad 500001, Telangana, India
[2] Manipal Univ, Grad Studies, Manipal, Karnataka, India
[3] Nizams Inst Med Sci, Dept Med Genet, Hyderabad, Telangana, India
关键词
Molecular analysis; Mucopolysaccharidoses type VI; Novel mutation; Functional characterization; Pathogenic variant; Genotype-phenotype correlation; MISSENSE MUTATIONS; GENE; ARSB; N-ACETYLGALACTOSAMINE-4-SULFATASE; IDENTIFICATION; MUTANT;
D O I
10.1016/j.gene.2016.11.005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MPS VI is an autosomal recessive disorder which occurs due to the deficiency of N-acetyl galactosamine-4-sulfatase (Arylsulfatase B - ARSB) involved in catabolism of dermatan sulfate resulting from disease-causing variations in the ARSB gene. Human Gene Mutation Database (HGMD) search revealed 200 different mutations in ARSB worldwide. In the present study we carried out molecular and functional analyses to characterize the mutations reported by us in Indian population. Mutation analysis of 19 MPS VI patients revealed presence of a total of 15 different mutations of which twelve were novel [p.Asp53Asn (c.157G>A; p.D53N), p.Leu98Arg (c.293T>G; p.L98R), p.Tyr103Serfs*9 (c.306_312delCTACCAG+146del; p.Y103Sfs*9), p.Phe166Leufs*18 (c.496delT; p.F166Lfs*18), p.Ile220Serfs*5 (c.659_660delTA; p.I220Sfs*5), p.Ile350Phe (c.1048A>T; p.I350F), p.Trp353* (c.1059G>A; p.W353*), p.His393Arg (c.1178A>G; p.H393R), p.Ser403Tyrfs* (c.1208delC; p.S403Yfs*), p.Pro445Leu (c.1334C>T; p.P445L), p.Trp450Leu (c.1349G>T; p.W450L) and p.Trp450Cys (c.1350G>C; p.W450C)] and three were known mutations [p.Asp54Asn (c.160G>A; p.D54N), p.Ala237Asp (c.710C>A; p.A237D) and p.Ser320Arg (c.960C>G; p.S320R)]. Functional characterization using site-directed mutagenesis followed by cell transfection assays, immunoblot, reverse transcriptase PCR and immunofluorescence studies for the putative pathogenic variants detected in our MPS VI patient cohort helped us to confirm the pathogenic potential of the variants in ARSB. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 50 条
  • [21] COMPRESSIVE MYELOPATHY ASSOCIATED WITH TYPE-VI MUCOPOLYSACCHARIDOSIS (MAROTEAUX-LAMY SYNDROME)
    WALD, SL
    SCHMIDEK, HH
    NEUROSURGERY, 1984, 14 (01) : 83 - 88
  • [22] Maroteaux-Lamy Syndrome (Mucopolysaccharidosis VI) Presenting as Familial Myelopathy
    Modi, Manish
    Singla, Veenu
    Khandelwal, Niranjan
    Prabhakar, S.
    Duberkar, Dhananjay
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 (06) : 337 - 340
  • [23] Growth charts for individuals with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    Quartel, Adrian
    Graham, Sue
    Harmatz, Paul
    Lin, Ping
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S88 - S89
  • [24] DISTINCT BIOCHEMICAL DEFICIT IN MAROTEAUX-LAMY SYNDROME (MUCOPOLYSACCHARIDOSIS VI)
    BARTON, RW
    NEUFELD, EF
    JOURNAL OF PEDIATRICS, 1972, 80 (01): : 114 - +
  • [25] Umbilical cord blood transplantation for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)
    Lee, V
    Li, CK
    Shing, MMK
    Chik, KW
    Lam, CW
    Tsang, KS
    Pong, H
    Huen, KF
    Yuen, PMP
    BONE MARROW TRANSPLANTATION, 2000, 26 (04) : 455 - 458
  • [26] Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    Harmatz, P
    Whitley, CB
    Waber, L
    Pais, R
    Steiner, R
    Plecko, B
    Kaplan, P
    Simon, J
    Butensky, E
    Hopwood, JJ
    JOURNAL OF PEDIATRICS, 2004, 144 (05): : 574 - 580
  • [27] Evaluation of galsulfase for the treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    Lourenco, Charles Marques
    Giugliani, Roberto
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 407 - 417
  • [28] The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI):: A case report
    Alpöz, AR
    Çoker, M
    Çelen, E
    Ersin, NK
    Gökçen, D
    van Diggelenc, OP
    Huijmansc, JGM
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2006, 101 (05): : 632 - 637
  • [29] HIGH PREVALENCE OF MENTAL IMPAIRMENT IN A SERIES OF 6 PATIENTS WITH MUCOPOLYSACCHARIDOSIS TYPE VI (MAROTEAUX-LAMY SYNDROME)
    Valayannopoulos, V.
    Barbier, V.
    Boddaert, N.
    Arnoux, J. B.
    Lemerrer, M.
    de Lonlay, P.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 80 - 80
  • [30] Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) in the pre-Columbian culture of Colombia
    Pachajoa, Harry
    Armando Rodriguez, Carlos
    COLOMBIA MEDICA, 2014, 45 (02): : 85 - 87